Dermatology Company Announces Six Exclusive License Agreements
Sol-Gel Technologies Announces Six Exclusive License Agreements to Commercialize TWYNEO® and EPSOLAY® in Europe and South Africa.
Disclaimer: The information in this article is intended for informational purposes only. It reflects recent business developments related to Sol-Gel Technologies and should not be construed as financial advice, endorsements, or commercial promotions.
Real-time information is available daily at https://stockregion.net